Stock Report

Artemis' Consolidated Revenue from Operations up 16.4% in Q4 FY26 YoY, EBITDA up 23.1%; Net Profit up 32.1%



Posted On : 2026-05-10 14:38:10( TIMEZONE : IST )

Artemis' Consolidated Revenue from Operations up 16.4% in Q4 FY26 YoY, EBITDA up 23.1%; Net Profit up 32.1%

The Board of Directors of Artemis Medicare Services Ltd today approved the company's financial results for the Q4 FY26 and FY26.

For the quarter ended March 31, 2026, Artemis Medicare Services Ltd, on a consolidated level, registered a revenue from operations of Rs 27,923 Lacs, an increase of 16.4% over the same period last fiscal year.

Quarterly Artemis Hospital Gurgaon Performance Highlights

Q4 FY2025-26 vs Q4 FY2024-25

- Average revenue per occupied bed (ARPOB) at Rs 84,571, against Rs 78,835
- Revenue from operations up by 18.8% at Rs 26,746 Lacs, against Rs 22,520 Lacs
- EBITDA of Rs 5,804 Lacs against Rs 4,814 Lacs, growth of 20.6%
- PAT of Rs 3,136 Lacs against Rs 2,617 Lacs, growth of 19.8%
- Bed capacity utilisation stood at 64.6%
- Revenue from overseas patients increased by 13.5% to Rs 8,226 Lacs from Rs 7,247 Lacs
- Overseas patients contributed 30.8% to Net Revenue from operations
- Average length of stay (ALOS) remains constant at 3.6 days

Quarterly Consolidated Performance Highlights

Q4 FY2025-26 vs Q4 FY2024-25

- Revenue from operations up by 16.4% at Rs 27,923 Lacs, against Rs 23,990 Lacs
- EBITDA of Rs 5,938 Lacs against Rs 4,824 Lacs, growth of 23.1%
- PAT of Rs 3,028 Lacs against Rs 2,292 Lacs, growth of 32.1%

FY26 Artemis Hospital Gurgaon Performance Highlights

FY2025-26 vs FY2024-25

- Average revenue per occupied bed (ARPOB) at Rs 82,435, against Rs 76,447
- Revenue from operations up by 17.8% at Rs 1,03,022 Lacs, against Rs 87,424 Lacs
- EBITDA of Rs 21,785 Lacs against Rs 18,590 Lacs, growth of 17.2%
- PAT of Rs 11,336 Lacs against Rs 9,837 Lacs, growth of 15.2%
- Bed capacity utilisation stood at 63.0%
- Revenue from overseas patients increased by 26.9% to Rs 32,268 Lacs from Rs 25,433 Lacs
- Overseas patients contributed 31.3% to Net Revenue
- Average length of stay (ALOS) remains constant at 3.6 days

FY26 Consolidated Performance Highlights

FY2025-26 vs FY2024-25

- Revenue from operations up by 15.4% at Rs 1,08,124 Lacs, against Rs 93,692 Lacs
- EBITDA of Rs 21,801 Lacs against Rs 18,478 Lacs, growth of 18.0%
- PAT of Rs 10,372 Lacs against Rs 8,218 Lacs, growth of 26.2%

Commenting on the company's performance, Mr. Onkar Kanwar, Chairman, Artemis Medicare Services Ltd said "We are pleased with our performance in the final quarter of FY26, which reflects steady progress and consistent execution across our operations. The year has been marked by sustained growth, improving profitability, and continued focus on delivering high-quality clinical outcomes and patient experience.

Our flagship Gurugram facility remained a key driver of performance, supported by a strong case mix, stable occupancy, and growing contribution from international patients. This underscores our positioning in high-acuity care and our continued strength in the Medical Value Travel segment."

Dr. Devlina Chakravarty, Managing Director, Artemis Medicare Services Ltd mentioned "Operational discipline and ongoing efficiency initiatives have supported improved profitability during the year, while ensuring that patient care and clinical outcomes remain at the core of our approach.

On the expansion front, we are making good progress on our upcoming Raipur facility, which represents an important step in extending our presence into new, high-growth markets. Going ahead, we will continue to focus on strengthening our clinical capabilities, enhancing operational efficiencies, and pursuing calibrated expansion, with the objective of building a resilient and future-ready healthcare platform."

Source : Equity Bulls

Keywords

ArtemisMedicareServices Q4FY26 Q4FY2026 FY26 FY2026 ResultUpdate